Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

In axial spondyloarthritis (SpA), the efficacy of certolizumab pegol (CZP), a novel pegylated anti-tumor necrosis factor alpha drug has not been investigated. We report that CZP showed a rapid effectiveness, assessed clinically and by magnetic resonance imaging, in a patient with a non-radiographic...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Spadaro (Author), A. Scarno (Author), A. Carboni (Author), F.M. Perrotta (Author), C. Catalano (Author), E. Lubrano (Author), G. Valesini (Author)
Format: Book
Published: PAGEPress Publications, 2013-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available